TI
BPMC

Trexquant Investment’s Blueprint Medicines BPMC Stock Holding History

Trexquant Investment’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-127,098
Closed -$11.1M – 1564
2024
Q4 		$11.1M Buy
127,098
+8,553
+7% +$783K 0.13% 235
2024
Q3 		$11M Sell
118,545
-14,698
-11% -$1.46M 0.14% 217
2024
Q2 		$14.4M Buy
133,243
+130,946
+5,701% +$13.1M 0.22% 106
2024
Q1 		$218K Sell
2,297
-54,635
-96% -$4.69M ﹤0.01% 1350
2023
Q4 		$5.25M Buy
+56,932
New +$3.69M 0.12% 236
2022
Q4 		– Sell
-91,922
Closed -$6.06M – 1384
2022
Q3 		$6.06M Buy
91,922
+86,523
+1,603% +$5.56M 0.21% 121
2022
Q2 		$273K Buy
+5,399
New +$316K 0.01% 1173
2020
Q4 		– Sell
-4,109
Closed -$381K – 1044
2020
Q3 		$381K Sell
4,109
-8,729
-68% -$672K 0.02% 821
2020
Q2 		$1M Sell
12,838
-21,585
-63% -$1.46M 0.07% 400
2020
Q1 		$2.01M Buy
34,423
+31,513
+1,083% +$2.03M 0.15% 215
2019
Q4 		$233K Buy
+2,910
New +$218K 0.01% 853
2019
Q3 		– Sell
-2,156
Closed -$203K – 874
2019
Q2 		$203K Buy
+2,156
New +$178K 0.02% 689
2019
Q1 		– Sell
-27,774
Closed -$1.5M – 1005
2018
Q4 		$1.5M Buy
27,774
+6,681
+32% +$406K 0.09% 328
2018
Q3 		$1.65M Buy
+21,093
New +$1.47M 0.12% 242
2018
Q2 		– Sell
-19,279
Closed -$1.77M – 914
2018
Q1 		$1.77M Buy
+19,279
New +$1.66M 0.12% 272
2017
Q2 		– Sell
-5,759
Closed -$230K – 806
2017
Q1 		$230K Buy
+5,759
New +$206K 0.03% 897
2016
Q2 		– Sell
-22,216
Closed -$401K – 885
2016
Q1 		$401K Sell
22,216
-6,698
-23% -$116K 0.05% 640
2015
Q4 		$762K Buy
+28,914
New +$651K 0.07% 506

Other funds holding BPMC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Trexquant Investment's BPMC Position: Q1 2025 in Review

Trexquant Investment sold out of Blueprint Medicines (BPMC) in Q1 2025, closing a stake of 127,098 shares — an estimated $11.1M sold.

Trexquant Investment first reported a position in BPMC in Q4 2015 and held it in 18 quarters. The position peaked at $14.4M in Q2 2024. 352 funds tracked by Wall St. Rank hold BPMC as of Q1 2025.

  • Trexquant Investment reported no remaining Blueprint Medicines position as of Q1 2025 after selling out during the quarter.
  • Trexquant Investment sold 127,098 Blueprint Medicines shares in Q1 2025, an estimated $11.1M.
  • Trexquant Investment first reported a position in Blueprint Medicines in Q4 2015 and held it in 18 quarters.
  • Trexquant Investment's Blueprint Medicines position peaked at $14.4M in Q2 2024.
  • 352 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2025.

Based on Trexquant Investment's 13F filing for Q1 2025, filed 14 May 2025.